Upstream Bio, Inc. (UPB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $7.90
• Market Cap: $1.26B
• EPS: $-6.40
• 52-Week High: $33.68
• 52-Week Low: $5.14

Market Sentiment

Upstream Bio, Inc. currently has a Bullish sentiment score of 0.29.

About Upstream Bio, Inc.

Upstream Bio, Inc. is a clinical-stage biotechnology firm based in Waltham, Massachusetts, dedicated to the advancement of innovative therapies for inflammatory diseases, with a particular emphasis on severe respiratory disorders. The company leverages cutting-edge research and development to address unmet medical needs in this specialty area. With a robust pipeline of therapeutic candidates, Upstream Bio is poised to make significant contributions to the treatment landscape for patients stru...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Upstream Bio, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does UPB pay dividends?

Upstream Bio, Inc. (UPB) does not currently pay a regular dividend.

What is UPB's market cap?

Upstream Bio, Inc. (UPB) has a market capitalization of $1.26B with a current stock price of $7.90.